| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | KRG | United States | $26.45 | $844,365,000.00 | Buy | 10 | 2004 |
#2 | TGTX | United States | $48.74 | $2,785,000.00 | Strong Buy | 5 | 2008 |
#3 | RSI | United States | $25.58 | $1,134,428,000.00 | Strong Buy | 10 | 2020 |
#4 | IVT | United States | $33.63 | $299,169,000.00 | Buy | 7 | 2005 |
#5 | SMG | United States | $60.94 | $3,016,500,000.00 | Buy | 6 | 2012 |
#6 | EYE | United States | $19.22 | $1,987,488,000.00 | Strong Buy | 9 | 2017 |
#7 | LEVI | United States | $22.57 | $6,282,000,000.00 | Strong Buy | 12 | 2019 |
#8 | VCYT | United States | $41.25 | $0.00 | Strong Buy | 7 | 2013 |
#9 | BXMT | United States | $14.48 | $0.00 | Buy | 5 | 1998 |
#10 | APEI | United States | $45.23 | $198,174,000.00 | Strong Buy | 7 | 2007 |
#11 | DRH | United States | $12.36 | $1,120,491,000.00 | Buy | 10 | 2004 |
#12 | SIRI | United States | $28.55 | $5,425,129,000.00 | Buy | 8 | 1996 |
#13 | PSTL | United States | $23.00 | $95,823,000.00 | Strong Buy | 4 | 2018 |
#14 | PCRX | United States | $23.00 | $541,533,000.00 | Strong Buy | 4 | 2010 |
#15 | TRNO | United States | $68.22 | $476,383,000.00 | Buy | 12 | 2009 |
#16 | BLLN | United States | $93.33 | $305,112,000.00 | Buy | 7 | 2025 |
#17 | LINC | United States | $29.94 | $261,853,000.00 | Strong Buy | 4 | 2005 |
#18 | CTRE | United States | $38.77 | $476,393,000.00 | Buy | 10 | 2013 |
#19 | BROS | United States | $52.02 | $1,638,159,000.00 | Strong Buy | 20 | 2021 |
#20 | PHIN | United States | $74.49 | $0.00 | Buy | 5 | 2023 |
#21 | MPLT | United States | $11.75 | $0.00 | Strong Buy | 7 | 2025 |
#22 | PECO | United States | $40.50 | $726,594,000.00 | Buy | 7 | 2010 |
#23 | CALY | United States | $16.48 | $2,060,100,000.00 | Buy | 4 | 1994 |
#24 | BIOA | United States | $10.60 | $8,995,000.00 | Strong Buy | 6 | 2024 |
#25 | PRVA | United States | $22.00 | $2,122,842,000.00 | Buy | 12 | 2021 |
#26 | LASR | United States | $52.60 | $191,359,000.00 | Strong Buy | 9 | 2018 |
#27 | EXEL | United States | $51.24 | $452,477,000.00 | Buy | 21 | 2000 |
#28 | HCSG | United States | $21.59 | $1,837,173,000.00 | Buy | 6 | 1994 |
#29 | LQDA | United States | $74.44 | $158,320,000.00 | Strong Buy | 11 | 2020 |
#30 | UTI | United States | $25.15 | $835,616,000.00 | Strong Buy | 4 | 2003 |
#31 | ESTA | United States | $79.47 | $61,208,000.00 | Strong Buy | 7 | 2018 |
#32 | ERAS | United States | $18.38 | $0.00 | Strong Buy | 12 | 2021 |
#33 | NAMS | Netherlands | $26.98 | $22,503,000.00 | Strong Buy | 8 | 2022 |
#34 | LMAT | United States | $82.38 | $249,602,000.00 | Buy | 5 | 2006 |
#35 | TNGX | United States | $25.60 | $62,384,000.00 | Strong Buy | 10 | 2020 |
#36 | CTVA | United States | $76.68 | $17,401,000,000.00 | Buy | 16 | 2018 |
#37 | BLBD | United States | $64.81 | $1,480,099,000.00 | Strong Buy | 6 | 2013 |
#38 | GTX | Switzerland | $29.00 | $3,584,000,000.00 | Strong Buy | 5 | 2021 |
#39 | NI | United States | $42.50 | $0.00 | Buy | 10 | 2018 |
#40 | NYT | United States | $64.79 | $1,783,639,000.00 | Buy | 7 | 1994 |
#41 | TCMD | United States | $24.20 | $0.00 | Strong Buy | 4 | 2016 |
#42 | PGNY | United States | $26.28 | $1,288,661,000.00 | Buy | 10 | 2019 |
#43 | NJR | United States | $55.60 | $1,351,305,000.00 | Buy | 4 | 1994 |
#44 | ROL | United States | $36.20 | $2,161,220,000.00 | Buy | 11 | 1994 |
#45 | BRX | United States | $29.98 | $1,371,597,000.00 | Buy | 12 | 2013 |
#46 | MAC | United States | $24.71 | $1,013,983,000.00 | Buy | 12 | 1994 |
#47 | HST | United States | $22.90 | $5,387,000,000.00 | Buy | 14 | 1998 |
#48 | DECK | United States | $93.09 | $5,472,296,000.00 | Buy | 23 | 1996 |
#49 | LOCO | United States | $15.54 | $401,701,000.00 | Buy | 4 | 2014 |
#50 | MNST | United States | $46.82 | $8,294,343,000.00 | Buy | 15 | 1996 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $100 to Buy (August 14, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.